Neonatal tetanus immunity in Nigeria: The effect of HIV infection on serum levels and transplacental transfer of antibodies

Journal of Tropical Medicine

Volumn 2016, Issue , 2016, Pages

  Bashir, Muhammad Faruk ^a   Elechi, Hassan Abdullahi ^b   Ashir, Mohammed Garba ^b   Rabasa, Adamu Ibrahim ^b   Bukbuk, David Nadeba ^b   Usman, Ahmadu Baba ^c   Mustapha, Modu Gofama ^b   Alhaji, Mohammad Arab ^b  

^a ABUBAKAR TAFAWA BALEWA UNIVERSITY   (Nigeria)

^b UNIVERSITY OF MAIDUGURI   (Nigeria)

^c Federal Medical Centre Yola   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

TETANUS ANTIBODY; TETANUS TOXOID;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD LEVEL; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN TETANUS; NIGERIA; PLACENTAL TRANSFER; PRIORITY JOURNAL; VACCINATION; YOUNG ADULT;

EID: 84958824615     PISSN: 16879686     EISSN: 16879694     Source Type: Journal    
DOI: 10.1155/2016/7439605     Document Type: Article

References (28)

1. S. D. Gupta and P. M. Keyl, "Effectiveness of prenatal tetanus toxoid immunization against neonatal tetanus in a rural area in India, " Pediatric InfectiousDisease Journal, vol. 17, no. 4, pp. 316-321, 1998.
2. K. W. Newell, L. A. Duenas, D. R. LeBlanc, and N. Garces Osorio, "The use of tetanus toxoid for the prevention of neonatal tetanus in developing countries for the prevention of tetanus neonatorum, " Bulletin of theWorld Health Organization, vol. 35, pp. 863-871, 1966.
3. R. E. Black, D. H. Huber, and G. T. Curlin, "Reduction of neonatal tetanus by mass immunization of non-pregnant women: duration of protection provided by one or two doses of aluminium-adsorbed tetanus toxoid, " Bulletin of the World Health Organization, vol. 58, no. 6, pp. 927-930, 1980.
4. G. G. Berggren, W. Berggren, and A. Verly, "Traditional midwives, tetanus immunization, and infant mortality in rural Haiti, " Tropical Doctor, vol. 13, no. 2, pp. 79-87, 1983.
5. J. Cliff, "Neonatal tetanus in Maputo, Mozambique Part II. Preventative measures, "Central AfricanJournal ofMedicine, vol. 31, no. 2, pp. 27-31, 1985.
6. J. Vandelaer, M. Birmingham, F. Gasse, M. Kurian, C. Shaw, and S. Garnier, "Tetanus in developing countries: an update on the maternal and neonatal tetanus elimination initiative, " Vaccine, vol. 21, no. 24, pp. 3442-3445, 2003.
7. T. N. Dieye, P. S. Sow, T. Simonart, et al., "Immunologic and virologic response after tetanus toxoid booster among HIV-1 and HIV-2-infected Senegalese individuals, " Vaccine, vol. 20, no. 5-6, pp. 905-913, 2002.
8. T. C. S. Bonetti, R. C. M. Succi, L. Y. Weckx, L. Tavares-Lopes, and M. I. DeMoraes-Pinto, "Tetanus and diphtheria antibodies and response to a booster dose in Brazilian HIV-1-infected women, " Vaccine, vol. 22, no. 27-28, pp. 3707-3712, 2004.
9. B. J. Okoko, L. H. Wesuperuma, M. O. Ota, et al., "Influence of placental malaria infection and maternal hypergammaglobulinaemia on materno-fetal transfer of measles and tetanus antibodies in a ruralwestAfrican population, " Journal ofHealth, Population, and Nutrition, vol. 19, no. 2, pp. 59-65, 2001.
10. M. I. DeMoraes-Pinto, F. Verhoeff, L. Chimsuku, et al., "Placental antibody transfer: influence of maternal HIV infection and placental malaria, " Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 79, no. 3, pp. F202-F205, 1998.
11. P. Cumberland, C. E. Shulman, P. A. C. Maple, et al., "Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya, " Journal of Infectious Diseases, vol. 196, no. 4, pp. 550-557, 2007.
12. WHO, "Immunisation, surveillance, assessment, and monitoring, " Maternal and Neonatal Tetanus (MNT) Elimination: 1-7, 2010.
13. W. G. Cochran, Sampling Techniques, JohnWiley and Sons, New York, NY, USA, 3rd edition, 1977.
14. N. U. Adabara, Y. T. Kandakai-Olukemi, M. N. Enenebeaku, and P. H. Daru, "Assessment of materno-foetal transfer of antitetanus immunoglobulin G in Jos University Teaching Hospital, Jos, " Shiraz E Medical Journal, vol. 11, no. 2, pp. 1-8, 2010.
15. B. J. Stoll and I. Adams-Chapman, "The high-risk infant, " in Nelson Textbook of Pediatrics, R. M. Kliegman, R. E. Behrman, H. B. Jenson, and B. F. Stanton, Eds., p. 97, Saunders, 18th edition, 2007.
16. G. A. Oyedeji, "Socioeconomic and cultural background of hospitalized children in Ilesha, " Nigerian Journal of Paediatrics, vol. 12, no. 4, pp. 111-117, 1985.
17. Product Information InstructionManual. Enzyme Immunoassay for the Detection and the Quantitative Determination of Human IGG Antibodies against Tetanus Toxoid in Serum and Plasma, Demeditec Diagnostics, Kiel, Germany, 2009.
18. WHO, "Tetanus vaccine: WHO position paper, " The Weekly Epidemiological Record, vol. 81, pp. 198-208, 2006.
19. WHO, "Global program on AIDS-recommendations for the selection and use ofHIVantibody tests, "Weekly Epidemiological Record, vol. 20, pp. 145-149, 1992.
20. Federal Republic of Nigeria, Global AIDS Response Country Progress Report, Nigeria, 2012, http://www.avert.org/hiv-aidsnigeria.htm#sthash.vQ1BO9Bk.dpuf.
21. C. T. Omisakin, A. J. Esan, K. A. Fasakin, et al., "Syphilis and Human Immunodeficiency virus co-infection among pregnant women in Nigeria: prevalence and trend, " International STD Research and Reviews, vol. 2, no. 2, pp. 94-100, 2014.
22. C. M. Chama, M. Bello, B. A. Ajayi, S. Zarma, and W. Gashau, "The use of highly active antiretroviral therapy for the prevention of mother-to-child transmission of the human immunodeficiency virus in Nigeria, " Journal of Obstetrics and Gynaecology, vol. 30, no. 4, pp. 362-366, 2010.
23. NACP, "National HIV prevalence sentinels survey among pregnant women in Nigeria, " Tech. Rep., Department of Public Health, NACP, FMOH, 2010.
24. N. Hood, M. C. K. Chan, S. M. Maxwell, J. B. Familusi, and C. A. Hart, "Placental transfer of tetanus toxoid antibodies in Nigerian mothers, " Annals of Tropical Paediatrics, vol. 14, no. 3, pp. 179-182, 1994.
25. F. T. Cutts, L. C. Rodriguez, S. Colombo, and S. Bennett, "Evaluation of factors influencing vaccine uptake in Mozambique, " International Journal of Epidemiology, vol. 18, no. 2, pp. 427-433, 1989.
26. J. L. Michaux, J. F. Heremans, and W. H. Hitzig, "Immunoglobulin levels in cord-blood serum of negroes and Caucasians, " Tropical and Geographical Medicine, vol. 18, no. 1, pp. 10-14, 1966.
27. V. Sangpetchsong, S. Vichaikummart, A. Vichitnant, and A. Podhipak, "Transfer rate of transplacental immunity to tetanus from non-immunized and immunized mothers, " Southeast Asian Journal of TropicalMedicine and Public Health, vol. 15, no. 3, pp. 275-280, 1984.
28. S. Y. Maselle, "Maternal and foetal tetanus toxoid antibody levels following immunization in pregnancy, " Journal ofObstetrics and Gynaecology of Eastern and Central Africa, vol. 8, pp. 11-14, 1989.